Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Recombinant human interleukin-1 receptor antagonist injection

Home DrugsRecombinant human interleukin-1 receptor antagonist injection

Recombinant human interleukin-1 receptor antagonist injection

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Recombinant human interleukin-1 receptor antagonist injection
Applicant: CHANGCHUN INST OF BIOLOGICAL PRODUCTS CO LTDPriority: 2024
CN
Recombinant human interleukin-1 receptor antagonist in-situ gel
Applicant: LI TONGPriority: 2010
CN
Active super-antigen compound biological injection preparation G for treating muscle and bone joint diseases and preparation method of active super-antigen compound biological injection preparation G
Applicant: LIN BOPriority: 2025
CN